Approvals/CIMA-AEMPS/RIVASTIGMINA STADAFARMA 13,3 MG/24 H PARCHES TRANSDERMICOS EFG

Approved

STANDARD

RIVASTIGMINA STADAFARMA 13,3 MG/24 H PARCHES TRANSDERMICOS EFG

Laboratorio Stada S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 0d9bef31d38cd15b
Drug Cima Aemps Name: RIVASTIGMINA STADAFARMA 13,3 MG/24 H PARCHES TRANSDERMICOS EFG
Register Number: 86086
Holder Company Name: Laboratorio Stada S.L.
Marketing Company Name: Laboratorio Stada S.L.
Authorization Date: 2021-07-11
Dosage Form: PARCHE TRANSDÉRMICO
Dose: 13,3 mg/24 h
Route Of Administration: VÍA TRANSDÉRMICA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Laboratorio Stada S.L.

RIVASTIGMINA

19.2 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 11, 2021

Approval ID

0d9bef31d38cd15b

Type

Standard